NCT02734953View on ClinicalTrials.gov

Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Nitric Oxide

Ambulatory inhaled nitric oxide delivery system and 6 minute walk distance test

Trial Locations (1)

15212

Allegheny General Hospital, Pittsburgh

All Listed Sponsors
lead

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

OTHER

NCT02734953 - Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH | Biotech Hunter | Biotech Hunter